Access Statistics for Andrew W. Lo

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Computational View of Market Efficiency 0 0 0 108 0 1 1 424
A Cost/Benefit Analysis of Clinical Trial Designs for COVID-19 Vaccine Candidates 0 0 0 46 0 0 0 155
A Dynamic Model of Optimal Investment and Financial Policies with Costs of Adjustment and Leverage 0 0 0 1 0 0 0 189
A Nonparametric Approach to Pricing and Hedging Derivative Securities Via Learning Networks 1 1 30 232 9 9 79 696
A Residuals-Based Wald Test for the Linear Simultaneous Equation 0 0 0 0 1 1 1 151
A Residuals-Based Wald Test for the Linear Simultaneous Equation 0 0 0 0 0 0 1 286
A Simple Specification Test of the Random Walk Hypothesis 0 0 0 2 1 1 7 1,010
A Survey of Systemic Risk Analytics 0 0 1 107 3 4 11 466
Accelerating Vaccine Innovation for Emerging Infectious Diseases via Parallel Discovery 0 0 0 3 1 3 4 13
An Econometric Analysis of Nonsynchronous Trading 1 1 1 358 2 2 5 840
An Econometric Analysis of Nonsyschronous-Trading 0 0 0 0 1 1 2 228
An Econometric Model of Serial Correlation and Illiquidity In Hedge Fund Returns 0 1 3 173 1 3 9 627
An Econometric Model of Serial Correlation and Illiquidity in Hedge Fund Returns 0 0 2 530 0 0 6 1,535
An Ordered Probit Analysis of Transaction Stock Prices 0 0 0 539 0 1 7 1,767
An Ordered Probit Analysis of Transaction Stock Prices 0 0 0 0 0 2 3 902
An Ordered Probit Analysis of Transaction Stock Prices (Reprint 029) 0 0 0 0 0 1 3 563
An ordered probit analysis of transaction stock prices 0 0 0 142 0 0 1 407
Asset Prices and Trading Volume Under Fixed Transactions Costs 0 0 1 145 3 4 8 704
Asset Prices and Trading Volume Under Fixed Transactions Costs 0 0 0 70 0 1 1 306
Asset Prices and Trading Volume Under Fixed Transactions Costs 0 0 0 2 0 0 0 5
Bayesian Adaptive Clinical Trials for Anti‐Infective Therapeutics during Epidemic Outbreaks 0 0 0 5 0 0 2 44
Competition and R&D Financing Decisions: Theory and Evidence from the Biopharmaceutical Industry 0 0 0 72 0 1 4 230
Data Snooping Biases in Tests of Financial Asset Pricing Models (Reprint 002) 0 0 0 1 0 0 3 341
Data-Snooping Biases in Tests of Financial Asset Pricing Models 0 0 0 145 0 1 3 519
Data-snooping biases in tests of financial asset pricing models 0 0 0 86 0 0 3 308
Econometric Measures of Connectedness and Systemic Risk in the Finance and Insurance Sectors 0 2 2 379 2 4 17 927
Econometric Measures of Systemic Risk in the Finance and Insurance Sectors 0 1 4 386 0 1 8 1,064
Econometric Models of Limit-Order Executions 0 0 1 165 0 0 1 745
Econometric Models of Limit-Order Executions 0 0 1 398 0 1 3 1,256
Estimating Probabilities of Success of Vaccine and Other Anti-Infective Therapeutic Development Programs 0 0 0 11 0 1 5 53
Estimating the Financial Impact of Gene Therapy in the U.S 0 0 0 15 0 0 4 54
Fear and Greed in Financial Markets: A Clinical Study of Day-Traders 0 2 3 307 2 10 19 1,404
Financial Intermediation and the Funding of Biomedical Innovation: A Review 1 1 2 14 1 1 10 32
Financing Vaccines for Global Health Security 0 0 0 25 0 1 2 60
Foundations of Technical Analysis: Computational Algorithms, Statistical Inference, and Empirical Implementation 0 1 24 1,855 4 11 85 4,115
Foundations of Technical Analysis: Computational Algorithms, Statistical Inference, and Empirical Implementation 0 0 3 1,318 0 1 12 2,368
Frontiers of Finance: Evolution and Efficient Markets 0 0 0 521 0 2 12 1,665
Games of Survival in the Newspaper Industry 0 0 0 0 0 0 0 236
Global realignment in financial market dynamics: Evidence from ETF networks 0 0 1 54 1 2 10 89
Hedge Funds: A Dynamic Industry In Transition 0 0 1 85 2 3 9 259
Hedge fund holdings and stock market efficiency 1 1 1 68 2 6 8 264
Implementing Option Pricing Models When Asset Returns Are Predictable 0 0 0 459 0 0 1 1,554
Implementing option pricing models when asset returns are predictable 0 0 0 80 0 0 1 251
Impossible Frontiers 0 0 0 65 0 0 1 302
Information Dissemination and Aggregation in Asset Markets with Simple Intelligent Traders 0 0 0 239 0 1 2 887
Is It Real, or Is It Randomized?: A Financial Turing Test 0 0 0 65 0 0 2 160
Is the FDA Too Conservative or Too Aggressive?: A Bayesian Decision Analysis of Clinical Trial Design 0 0 1 14 0 0 2 94
Logit Versus Discriminant Analysis: A Specification Test 0 0 0 1 0 1 2 509
Long-term Memory in Stock Market Prices 0 0 2 286 1 2 14 955
Long-term memory in stock market prices 0 0 0 166 0 1 5 562
Maximizing Predictability in the Stock and Bond Markets 0 0 1 748 0 1 5 2,071
Maximizing predictability in the stock and bond markets 0 0 0 97 0 0 3 371
Maximum Likelihood Estimation of Generalized Ito Processes with Discretely Sampled Data 0 0 0 0 0 1 2 266
Maximum Likelihood Estimation of Generalized Ito Processes with Discretely Sampled Data 0 0 0 407 0 1 2 1,053
Models of the term structure of interest rates 0 0 0 0 0 0 4 461
Moore's Law vs. Murphy's Law in the financial system: who's winning? 0 0 0 45 1 2 6 84
Nonparametric Estimation of State-Price Densities Implicit in Financial Asset Prices 0 0 0 1 0 1 2 482
Nonparametric Estimation of State-Price Densities Implicit in Financial Asset Prices 0 0 0 576 0 3 5 2,019
Nonparametric Risk Management and Implied Risk Aversion 0 0 0 498 0 2 4 1,303
Optimal Financing for R&D-Intensive Firms 0 0 0 48 1 1 6 110
Paying off the Competition: Contracting, Market Power, and Innovation Incentives 0 0 1 54 2 2 11 128
Pricing and Hedging Derivative Securities in Incomplete Markets: An E-Aritrage Model 0 0 0 986 0 1 2 3,606
Pricing and hedging derivative securities in incomplete markets: an e-arbitrage approach 0 0 0 76 0 0 0 290
Privacy-Preserving Methods for Sharing Financial Risk Exposures 0 0 0 15 0 0 1 77
Risk and Risk Management in the Credit Card Industry 0 1 1 90 2 4 8 352
Sharing R&D Risk in Healthcare via FDA Hedges 0 0 0 28 0 2 3 93
Statistical Tests of Contingent Claims Asset-Pricing Models: A New Methodology (Revised: 10-85) 0 0 0 0 0 0 1 150
Statistical Tests of Contingent Claims Asset-Pricing Models: A New Methodology (Revision of 19-84) 0 0 0 0 0 1 2 183
Stock Market Prices Do Not Follow Random Walks: Evidence From a Simple Specification Test 2 4 17 983 4 11 55 3,211
Stock Market Prices Do Not Follow Random Walks: Evidence from a Simple Specification Test (Revised: 29-87) 0 0 0 0 2 3 9 460
Stock Market Prices Do Not Follow Random Walks: Evidence from a Simple Specification Test (Revised: 29-87) 0 0 0 0 0 2 4 228
Stock Market Prices Do Not Follow Random Walks: Evidence from a Simple Specification Test (Revision of 5-87) 0 0 0 0 0 0 5 349
Systemic Risk and Hedge Funds 0 0 1 823 0 1 8 2,224
Systemic Risk and the Refinancing Ratchet Effect 0 0 0 162 0 2 6 562
Systemic Risk and the Refinancing Ratchet Effect 0 0 1 125 0 1 2 550
The Gordon Gekko Effect: The Role of Culture in the Financial Industry 0 0 0 93 0 0 2 291
The Psychophysiology of Real-Time Financial Risk Processing 1 4 6 166 3 8 17 641
The Size and Power of the Variance Ratio Test in Finite Samples: A Monte Carlo Investigation 0 0 0 0 0 0 2 999
The Size and Power of the Variance Ratio Test in Finite Samples: A Monte Carlo Investigation 0 0 0 472 0 1 4 1,572
The Sources and Nature of Long-Term Memory in the Business Cycle 0 0 0 1 0 0 1 216
The Sources and Nature of Long-Term Memory in the Business Cycle 0 0 0 0 0 0 2 508
The Sources and Nature of Long-term Memory in the Business Cycle 0 0 0 90 0 0 1 463
The sources and nature of long-term memory in the business cycle 0 0 0 40 0 0 0 298
Trading Volume: Definitions, Data Analysis, and Implications of Portfolio Theory 0 0 0 665 0 0 2 2,285
Trading Volume: Implications of An Intertemporal Capital Asset Pricing Model 0 0 0 233 0 0 0 770
WARNING: Physics Envy May Be Hazardous To Your Wealth! 0 1 5 427 0 3 9 1,288
What Happened To The Quants In August 2007?: Evidence from Factors and Transactions Data 0 0 3 260 2 4 20 881
When Do Stop-Loss Rules Stop Losses? 0 0 4 157 1 4 14 537
When are Contrarian Profits Due to Stock Market Overreaction (Reprint 001) 0 0 0 4 0 2 3 491
When are Contrarian Profits Due to Stock Market Overreaction (Reprint 001) 0 0 0 0 1 3 6 272
When are Contrarian Profits Due to Stock Market Overreaction? 0 0 3 408 0 2 8 1,157
When are contrarian profits due to stock market overreaction? 0 0 1 147 1 1 5 440
Total Working Papers 7 21 128 18,668 57 155 651 66,373


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Nonparametric Approach to Pricing and Hedging Derivative Securities via Learning Networks 0 0 4 117 4 5 26 493
A Survey of Systemic Risk Analytics 2 3 12 449 2 5 28 1,450
A computational view of market efficiency 0 0 0 20 0 0 2 160
A large-sample chow test for the linear simultaneous equation 0 0 0 117 0 0 2 358
An Evolutionary Model of Bounded Rationality and Intelligence 0 0 0 0 0 0 0 6
An econometric analysis of nonsynchronous trading 2 2 7 452 4 4 17 1,114
An econometric model of serial correlation and illiquidity in hedge fund returns 1 2 9 213 3 9 39 968
An ordered probit analysis of transaction stock prices 0 1 3 567 0 1 11 1,426
Asset Prices and Trading Volume under Fixed Transactions Costs 0 0 0 26 2 2 5 428
Asset allocation and derivatives 1 1 1 20 1 2 3 126
Can Financial Economics Cure Cancer? 0 0 0 1 0 0 0 21
Can Financial Engineering Cure Cancer? 0 0 2 57 1 2 8 267
Can hedge funds time market liquidity? 0 0 1 41 0 0 5 311
Consumer credit-risk models via machine-learning algorithms 9 26 87 779 21 57 257 2,398
Data-Snooping Biases in Tests of Financial Asset Pricing Models 0 1 4 618 1 3 14 1,801
Econometric measures of connectedness and systemic risk in the finance and insurance sectors 8 9 44 655 13 27 116 2,017
Econometric models of limit-order executions 0 0 1 198 1 2 10 567
Estimating the NIH Efficient Frontier 0 0 0 0 0 0 0 3
Fear and Greed in Financial Markets: A Clinical Study of Day-Traders 0 0 1 147 3 8 18 696
Foundations of Technical Analysis: Computational Algorithms, Statistical Inference, and Empirical Implementation 2 4 10 25 5 11 33 101
Hamilton’s rule in economic decision-making 0 0 0 11 0 1 2 23
Hedge Fund Holdings and Stock Market Efficiency 0 0 2 13 0 1 10 67
Hedge Funds: A Dynamic Industry in Transition 0 0 1 21 1 1 11 126
Hedging Derivative Securities and Incomplete Markets: An (epsilon)-Arbitrage Approach 0 0 2 12 0 1 10 53
Identifying and Mitigating Potential Biases in Predicting Drug Approvals 0 0 1 3 0 0 2 10
Illiquidity Premia in Asset Returns: An Empirical Analysis of Hedge Funds, Mutual Funds, and US Equity Portfolios 0 0 2 24 3 3 33 181
Implementing Option Pricing Models When Asset Returns Are Predictable 0 0 1 148 0 0 4 494
Impossible Frontiers 0 1 1 15 0 1 2 260
Innovation at MIT 0 0 0 3 0 0 2 54
Introduction to Volume 5 of the Annual Review of Financial Economics 0 0 0 18 0 0 2 99
Is the FDA too conservative or too aggressive?: A Bayesian decision analysis of clinical trial design 0 2 6 24 2 8 23 128
Logit versus discriminant analysis: A specification test and application to corporate bankruptcies 0 0 2 401 0 1 5 762
Long-Term Memory in Stock Market Prices 1 3 11 1,284 2 6 36 4,624
MAXIMIZING PREDICTABILITY IN THE STOCK AND BOND MARKETS 0 0 1 69 0 0 3 353
Macroeconomic Models for Monetary Policy: A Critical Review from a Finance Perspective 0 0 3 23 0 1 14 70
Maximum Likelihood Estimation of Generalized Itô Processes with Discretely Sampled Data 0 0 2 42 0 0 4 142
Moore's Law versus Murphy's Law: Algorithmic Trading and Its Discontents 0 0 1 61 1 3 8 237
Nonparametric risk management and implied risk aversion 0 0 4 521 1 5 21 1,290
Optimal control of execution costs 2 4 12 853 5 10 39 1,821
Preface to the Annual Review of Financial Economics 0 0 0 53 0 0 1 230
Privacy-Preserving Methods for Sharing Financial Risk Exposures 0 0 0 23 0 0 0 180
Reading about the Financial Crisis: A Twenty-One-Book Review 0 2 5 441 1 7 14 1,308
Regulatory reform in the wake of the financial crisis of 2007‐2008 0 0 1 50 1 3 13 337
Reply to “(Im)Possible Frontiers: A Comment†0 0 1 16 0 3 4 68
Return Smoothing, Liquidity Costs, and Investor Flows: Evidence from a Separate Account Platform 0 0 2 3 0 0 4 13
Risk and risk management in the credit card industry 0 1 4 39 2 6 20 222
Robert C. Merton: The First Financial Engineer 1 1 4 13 1 2 8 38
Robust ranking and portfolio optimization 1 1 3 40 1 1 7 121
Semi-parametric upper bounds for option prices and expected payoffs 0 0 2 210 0 0 3 372
Spectral factor models 2 2 13 32 2 3 27 105
Statistical tests of contingent-claims asset-pricing models: A new methodology 0 0 1 78 0 0 3 213
Stock Market Prices do not Follow Random Walks: Evidence from a Simple Specification Test 0 0 6 1,518 2 6 29 3,727
Systemic risk and the refinancing ratchet effect 1 2 2 87 1 2 5 569
THE ECONOMETRICS OF FINANCIAL MARKETS 7 13 68 579 27 40 170 1,597
The Derivatives Sourcebook 0 1 2 62 2 8 17 385
The Gordon Gekko effect: the role of culture in the financial industry 1 2 2 59 4 8 15 405
The Origin of Behavior 0 0 2 12 0 0 5 49
The Visible Hand 0 0 1 6 0 0 1 31
The growth of relative wealth and the Kelly criterion 0 1 1 17 0 1 5 84
The origin of cooperation 0 0 1 2 0 0 3 18
The size and power of the variance ratio test in finite samples: A Monte Carlo investigation 0 0 1 453 1 1 8 1,057
The sources and nature of long-term memory in aggregate output 0 0 0 80 0 0 1 436
To maximize or randomize? An experimental study of probability matching in financial decision making 0 0 0 2 0 0 1 12
Trading Volume: Definitions, Data Analysis, and Implications of Portfolio Theory 0 0 0 1 1 1 8 962
Trading Volume: Implications of an Intertemporal Capital Asset Pricing Model 0 0 1 117 1 3 8 472
Variety Is the Spice of Life: Irrational Behavior as Adaptation to Stochastic Environments 0 0 0 12 0 1 2 114
What happened to the quants in August 2007? Evidence from factors and transactions data 1 1 14 382 7 16 70 1,579
When Are Contrarian Profits Due to Stock Market Overreaction? 1 1 5 983 1 3 23 2,770
When do stop-loss rules stop losses? 1 2 13 156 3 6 34 577
When is time continuous? 0 0 2 110 0 1 5 472
Total Journal Articles 44 89 395 13,684 134 302 1,339 44,028
1 registered items for which data could not be found


Book File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Hedge Funds: An Analytic Perspective Updated Edition 0 0 0 0 0 2 16 154
Quantifying Systemic Risk 0 0 0 0 0 0 1 432
The Industrial Organization and Regulation of the Securities Industry 0 0 0 0 0 1 2 187
Total Books 0 0 0 0 0 3 19 773


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Accelerating Vaccine Innovation for Emerging Infectious Diseases via Parallel Discovery 0 0 0 7 0 3 5 29
Econometric Measures of Connectedness and Systemic Risk in the Finance and Insurance Sectors 0 0 0 0 0 3 14 190
IT'S 11 PM—DO YOU KNOW WHERE YOUR LIQUIDITY IS?: THE MEAN–VARIANCE–LIQUIDITY FRONTIER 0 0 1 5 0 1 5 28
Introduction 0 0 0 8 0 0 0 16
Introduction to "Quantifying Systemic Risk" 0 0 0 62 0 0 1 139
Introduction to "The Industrial Organization and Regulation of the Securities Industry" 0 0 1 20 0 0 1 89
SIFTING THROUGH THE WRECKAGE: LESSONS FROM RECENT HEDGE-FUND LIQUIDATIONS 0 0 0 2 0 0 2 11
Systemic Risk and Hedge Funds 0 0 2 142 1 1 4 425
WHEN IS TIME CONTINUOUS? 0 0 0 5 1 1 2 20
Where To From Here? 0 0 0 3 0 0 1 29
Total Chapters 0 0 4 254 2 9 35 976


Statistics updated 2025-05-12